For example, several studies identified new roles of SNRPA1 in the progression of CRC, classifying it as a potential therapeutic target in the treatment of CRC [44] and showing that the upregulation of this gene was associated with a worst prognostic [45]. This evidence concerns the gene SNRPA1 and colorectal carcinoma.